Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.360
+0.140 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
4.510
+0.150 (3.44%)
After-hours: Mar 9, 2026, 7:35 PM EDT

Cytek Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5606498391,1921,3822,183
Market Cap Growth
-16.32%-22.58%-29.66%-13.74%-36.68%-
Enterprise Value
325.26402.22569.29940.841,0561,819
Last Close Price
4.365.056.499.1210.2116.32
PE Ratio
--9.71-129.80-101.33510.50-
Forward PE
--26.14245.0644.39152.95
PS Ratio
2.793.224.186.188.4317.06
PB Ratio
1.591.902.123.033.255.39
P/TBV Ratio
1.631.892.143.143.333.29
P/FCF Ratio
--74.0238.371883.29-62.888205.99
P/OCF Ratio
--138.5433.04225.74-113.00471.45
EV/Sales Ratio
1.612.002.844.876.4414.21
EV/EBITDA Ratio
--14.16-56.74-50.54273.87174.87
EV/EBIT Ratio
--9.96-27.74-33.79-585.24198.59
EV/FCF Ratio
--45.8626.051486.31-48.046836.54
Debt / Equity Ratio
0.040.040.020.030.030
Debt / EBITDA Ratio
-0.51-0.51-0.86-0.603.78-
Debt / FCF Ratio
-1.66-1.660.3917.58-0.66-
Net Debt / Equity Ratio
-0.72-0.72-0.68-0.64-0.77-0.90
Net Debt / EBITDA Ratio
8.698.6926.8413.50-84.71-35.06
Net Debt / FCF Ratio
28.1628.16-12.32-396.9714.86-1370.74
Asset Turnover
0.420.420.400.380.330.37
Inventory Turnover
--2.941.531.571.77
Quick Ratio
4.164.165.005.667.9511.89
Current Ratio
5.045.045.866.979.2613.01
Return on Equity (ROE)
-18.05%-18.05%-1.53%-2.97%0.60%1.04%
Return on Assets (ROA)
-18.02%-18.74%-4.36%-4.25%-0.72%1.37%
Return on Invested Capital (ROIC)
-47.46%-49.36%-10.74%-11.92%-3.06%7.58%
Return on Capital Employed (ROCE)
-9.90%-9.90%-4.72%-6.13%-0.40%2.94%
Earnings Yield
-11.82%-10.30%-0.77%-0.99%0.20%0.00%
FCF Yield
-1.56%-1.35%2.61%0.05%-1.59%0.01%
Buyback Yield / Dilution
2.09%2.09%2.25%3.42%-0.20%-9.91%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q